NCT05759572 2024-02-06Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast CancerFudan UniversityPhase 2 Recruiting145 enrolled
NCT03086785 2018-01-17Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast CancerHebei Medical University Fourth HospitalPhase 2 Unknown120 enrolled